|
ATCC
human osteoblast like cell line mg63 ![]() Human Osteoblast Like Cell Line Mg63, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+osteoblast-like+cell+line+mg63/MG-63/10__1096_slash_fj__202201958r-38-0-16 Average 98 stars, based on 1 article reviews
human osteoblast like cell line mg63 - by Bioz Stars,
2026-09
98/100 stars
|
Buy from Supplier |
|
Procell Inc
mg63 human osteoblast-like cell line ![]() Mg63 Human Osteoblast Like Cell Line, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+osteoblast-like+cell+line+mg63/mg63/pm40149590-90-1-9 Average 90 stars, based on 1 article reviews
mg63 human osteoblast-like cell line - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
ATCC
human osteoblast like mg63 cell line ![]() Human Osteoblast Like Mg63 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+osteoblast-like+cell+line+mg63/MG-63/10__1002_slash_admt__202201802-289-0-5 Average 98 stars, based on 1 article reviews
human osteoblast like mg63 cell line - by Bioz Stars,
2026-09
98/100 stars
|
Buy from Supplier |
|
ATCC
mg63 human osteoblast like cell line ![]() Mg63 Human Osteoblast Like Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+osteoblast-like+cell+line+mg63/MG-63/pm32442267-58-44-50 Average 98 stars, based on 1 article reviews
mg63 human osteoblast like cell line - by Bioz Stars,
2026-09
98/100 stars
|
Buy from Supplier |
Journal: The FASEB Journal
Article Title: Interaction between ferroptosis and
doi: 10.1096/fj.202201958r
Figure Lengend Snippet: FIGURE 4 TNF-α modulates susceptibility to ferroptosis in MG63 and HUVEC. (A) The TNFR2 /TNFR1 mRNA expression ratio determined by qRT-PCR analysis in MG63 and HUVEC at 72 h after exposure to TNF-α. (B) Detection and quantitative analysis of intracellular ROS production in MG63 and HUVEC upon 72 h TNF-α treatment using DCFH-DA probes. Scale bar: 50 μm. (C,D) Relative mRNA expression of TNFR2 in MG63 and HUVEC transfected with scrambled siRNA (snc) or siRNA (siRNA #1 and siRNA#2) targeting TNFR2. (E,F) Western blotting analysis of SLC7A11,GCLC and GCLM in MG63 and HUVEC transfected with scrambled siRNA (snc) and siRNA#1 targeting TNFR2, and subsequently treated with TNF-α for 72 h. (G,H) Relative cell viability of MG63 and HUVEC primed with TNF-α for 72 h, followed by different concentrations of erastin treatment. Data are shown as mean ± SD representative of three independent experiments. *p < .05; **p < .01; ***p < .001.
Article Snippet:
Techniques: Expressing, Quantitative RT-PCR, Transfection, Western Blot
Journal: The FASEB Journal
Article Title: Interaction between ferroptosis and
doi: 10.1096/fj.202201958r
Figure Lengend Snippet: FIGURE 5 TNF-α rescues osteogenic and angiogenic dysfunctions caused by low-dose erastin through ferroptosis inhibition. After 7 days of osteogenic differentiation, (A,B) Relative mRNA expression of RUNX2 and COL1A1. (C–E) Western blotting analysis of RUNX2 and COL1A1 in MG63 treated with vehicle (DMSO), erastin, or both erastin and TNF-α. (F–H) Images and quantification analysis of capillary-like structures formed by HUVECs treated with vehicle (DMSO), erastin, or both erastin and TNF-α in the tube formation assay. Scale bar:100 μm. Data are shown as mean ± SD representative of three independent experiments. *p < .05; **p < .01; ***p < .001.
Article Snippet:
Techniques: Inhibition, Expressing, Western Blot, Tube Formation Assay
Journal: The FASEB Journal
Article Title: Interaction between ferroptosis and
doi: 10.1096/fj.202201958r
Figure Lengend Snippet: FIGURE 6 Ferroptosis inhibitors suppress the cytotoxicity of TNF-α on MG63 and HUVEC. (A,B) Intracellular ROS levels in MG63 and HUVEC treated with vehicle (DMSO), TNF-α, TNF-α+ ferrostatin-1 (Fer-1), or TNF-α+ deferoxamine (DFO). After 7 days of osteogenic induction, (C) relative mRNA expression of ALP (D) Representative images of ALP staining, (E) Western blotting analysis of RUNX2 and COL1A1 in MG63 treated with vehicle (DMSO), TNF-α, TNF-α+ ferrostatin-1 (Fer-1), or TNF-α+ deferoxamine (DFO). (F–H) Images and quantification analysis of capillary-like structures formed by HUVECs treated with vehicle (DMSO), TNF-α, TNF-α +ferrostatin-1 (Fer-1), or TNF-α+ deferoxamine (DFO). Data are shown as mean ± SD representative of three independent experiments. *p < .05; **p < .01; ***p < .001.
Article Snippet:
Techniques: Expressing, Staining, Western Blot
Journal: The FASEB Journal
Article Title: Interaction between ferroptosis and
doi: 10.1096/fj.202201958r
Figure Lengend Snippet: FIGURE 7 Schematic diagram illustrating the interaction between TNF-α and ferroptosis in MG63 and HUVEC.
Article Snippet:
Techniques:
Journal: Advanced Materials Technologies
Article Title: Influence of Initial Surface Roughness on LIPSS Formation and Its Consecutive Impact on Cell/Bacteria Attachment for TiAl6V4 Surfaces
doi: 10.1002/admt.202201802
Figure Lengend Snippet: Figure 7. Behavior of MG63 osteoblastic cells on unpolished and polished laser modified TiAl6V4 alloy. A) Cell viability, B) alkaline phosphatase activity, and C) low magnification SEM representative images. *Significantly different from the respective unlasered control, p ⩽0.05.
Article Snippet:
Techniques: Activity Assay, Control